Tumor Immunotherapy
Cancer Vaccines
Targeted Cancer Therapies
Targeted Cancer Therapies
Cancer Therapies
Cancer Therapies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 20, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, 1959 NE Pacific St, Seattle, WA 98195, United States; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, 850 Republican St, Seattle, WA 98195, United States.
No abstract available in PubMed .